倫敦証券交易所拒絕港交所(00388.HK)提約
香港交易所(00388.HK)公布,倫敦証券交易所集團拒絕港交所提出的可能要約。港交所已向倫敦証券交易所集團表明,已就是次計劃進行詳盡的準備工作。此外,亦曾與相關的監管機構及決策者進行初步的建設性討論。
港交所聲明指,期望與倫敦証券交易所集團董事會進行建設性的對話,但對倫敦証券交易所集團拒絕正面洽談感到失望。同時,希望證明所提出的合併建議遠比倫敦証券交易所集團收購Refinitiv的計劃更可取。
港交所董事會仍然相信,是次的建議對股東、客戶及環球資本市場整體來說都有重大裨益。認為倫敦証券交易所集團的股東應有機會詳細分析兩項交易,並會繼續與他們接洽。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.